229
Views
0
CrossRef citations to date
0
Altmetric
Review

A Delphi consensus statement for the management of post-COVID interstitial lung disease

ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , , , , , ORCID Icon, , , , , , , ORCID Icon, , , , , ORCID Icon, , & show all
Pages 983-995 | Received 14 Jun 2022, Accepted 22 Sep 2022, Published online: 30 Sep 2022
 

ABSTRACT

Introduction

As millions of people worldwide recover from COVID-19, a substantial proportion continue to have persistent symptoms, pulmonary function abnormalities, and radiological findings suggestive of post-COVID interstitial lung disease (ILD). To date, there is limited scientific evidence on the management of post-COVID ILD, necessitating a consensus-based approach.

Areas covered

A panel of experts in pulmonology and thoracic radiology was constituted. Key questions regarding the management of post-COVID ILD were identified. A search was performed on PubMed and EMBASE and updated till 1 March 2022. The relevant literature regarding the epidemiology, pathophysiology, diagnosis and treatment of post-COVID ILD was summarized. Subsequently, suggestions regarding the management of these patients were framed, and a consensus was obtained using the Delphi approach. Those suggestions which were approved by over 80% of the panelists were accepted. The final document was approved by all panel members.

Expert opinion

Dedicated facilities should be established for the care of patients with post-COVID ILD. Symptom screening, pulmonary function testing, and thoracic imaging have a role in the diagnosis. The pharmacologic and non-pharmacologic options for the management of post-COVID ILD are discussed. Further research into the pathophysiology and management of post-COVID ILD will improve our understanding of this condition.

Article highlights

  • Post-COVID interstitial lung disease (ILD) is a common sequela among patients hospitalized with acute COVID-19.

  • Symptom screening, pulmonary function testing, and thoracic imaging have a role in the diagnosis and follow-up for post-COVID ILD.

  • To date, there is limited scientific evidence on the management of post-COVID ILD.

  • This document uses the Delphi method to offer consensus-based suggestions on the diagnosis and management of post-COVID ILD.

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 362.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.